Mar 4, 2005 by Brian GormanLights, Camera, AmazonAmazon's latest broadband experiment may actually connect.
Mar 3, 2005 by Brian GormanBayer Heals ItselfThe latest earnings report suggests things are looking up -- and drug development may soon yield more good news.
Mar 2, 2005 by Brian GormanMonsanto's Brazil BenefitBrazil is on the cusp of legalizing genetically modified seed sales, a potential boon for Monsanto.
Mar 1, 2005 by Brian GormanXM's Price UptickThe service is probably worth $12.95 a month, but investors shouldn't look for further price increases.
Feb 28, 2005 by Brian GormanMedco Covers Its BasesMedco's purchase of Accredo is a nod to future growth in biotech drug spending.
Feb 25, 2005 by Brian GormanOmnicare's Grace Under PressureThe pharmacy services provider is responding well to the challenges in its business.
Feb 24, 2005 by Brian GormanFLYi Retains IndependenceThe airline has dodged liquidation but still faces challenges.
Feb 23, 2005 by Brian GormanAmgen Gets DisciplinedDirect-to-consumer advertising may be a non-starter for Amgen and other biotech companies.
Feb 22, 2005 by Brian GormanNovartis Embraces GenericsThe company is taking a different path from its branded pharmaceutical peers.
Feb 18, 2005 by Brian GormanMonsanto Cottons to EmergentMonsanto's second acquisition in less than a month signals an aggressive move into cotton seeds.
Feb 17, 2005 by Brian GormanAirbus Gets PoliticalThe aircraft maker is shopping a new factory to officials from 35 states. Boeing should be concerned.
Feb 16, 2005 by Brian GormanMedco's Double-Edged SwordSome of the pharmacy benefit manager's success is coming at the expense of retail pharmacies.
Feb 15, 2005 by Brian GormanKendle Grows With Client BaseThe contract drug research company shares surged as the firm showed signs of new life.
Feb 14, 2005 by Brian GormanGM Pulls Out of WalgreenThe pharmacy's mail-order policy spurs the automaker's cost-containment decision.
Feb 11, 2005 by Brian GormanThe New Sara LeeRestructuring will allow the company to concentrate on tackling some tough challenges.
Feb 10, 2005 by Brian GormanAutomakers Roll Out a SEMIGM, Ford, and DaimlerChrysler are collaborating to slow drug-cost increases.
Feb 9, 2005 by Brian GormanMGP's Recipe for a ReboundProducer of grain products has the potential to recover from the low-carb doldrums.
Feb 8, 2005 by Brian GormanABC's Non-Harsh RealityABC is seeking to replicate its Home Edition reality show's success with another feel-good premise.
Feb 7, 2005 by Brian GormanAlkermes Is Coming of AgeThe drug delivery company may soon have its own drug on the market.
Feb 4, 2005 by Brian GormanPepsiCo Drinks In SuccessPepsiCo's non-cola and international businesses are delivering impressive results.
